U.S. Markets open in 8 hrs 41 mins

  • S&P Futures

    4,073.00
    -11.75 (-0.29%)
     

  • Dow Futures

    32,522.00
    -59.00 (-0.18%)
     

  • Nasdaq Futures

    12,500.00
    -60.25 (-0.48%)
     

  • Russell 2000 Futures

    1,831.10
    -6.10 (-0.33%)
     

  • Crude Oil

    113.16
    +0.76 (+0.68%)
     

  • Gold

    1,807.00
    -11.90 (-0.65%)
     

  • Silver

    21.53
    -0.22 (-0.99%)
     

  • EUR/USD

    1.0537
    -0.0018 (-0.1686%)
     

  • 10-Yr Bond

    2.9680
    -2.9680 (-100.00%)
     

  • Vix

    26.10
    -27.47 (-100.00%)
     

  • GBP/USD

    1.2468
    -0.0024 (-0.1945%)
     

  • USD/JPY

    129.0200
    -0.3380 (-0.2613%)
     

  • BTC-USD

    29,841.74
    -483.62 (-1.59%)
     

  • CMC Crypto 200

    671.04
    +428.36 (+176.51%)
     

  • FTSE 100

    7,518.35
    +53.55 (+0.72%)
     

  • Nikkei 225

    26,832.96
    +173.21 (+0.65%)
     
Webinar:

Yahoo Finance Plus presents 'Investing in the new high-inflation, slowing-growth paradigm'

Analyst Callie Cox joins Jared Blikre to help investors find opportunities in a tough market on Wed, May 18 at 2pm ET.

Afya: Q3 Earnings Insights

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • AFYA

Shares of Afya (NASDAQ:AFYA) were unchanged in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share decreased 80.77% over the past year to $0.15, which missed the estimate of $0.23.

Revenue of $57,550,000 decreased by 72.16% from the same period last year, which missed the estimate of $59,430,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

View more earnings on AFYA

Revenue guidance hasn't been issued by the company for now.

Price Action

52-week high: $34.87

Company's 52-week low was at $13.98

Price action over last quarter: down 0.08%

Company Profile

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, Accounting Sciences, among others. The company offers Undergraduate courses, Preparatory Courses and Postgraduate studies. Its segments comprise of Education Services Segment and Residency Preparatory and Specialization Programs Segment.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories